Researchers evaluated a drug that represents a new class of anticoagulants known as Factor XI inhibitors for treating patients with atrial fibrillation as part of the AZALEA-TIMI 71 Study. The trial ...

Patients with atrial fibrillation are typically prescribed an anticoagulant, or blood thinner, to reduce the risk of stroke, but many may discontinue them or never receive a prescription due to ...

That's significant because the GI tract is the most common site of bleeding with DOACs, and this type of bleeding is the only one for which DOACs do not have a better risk profile ...

One of the most commonly used types of medication to prevent strokes is blood thinners. These medications reduce the risk of ...

Clinically significant reductions in bleeding underscore abelacimab’s strong potential to address an unmet need for patients ...

Saint Francis treated its first patient with pulsed-field ablation, which delivers pulsed electric fields to tissue to treat ...

Management of AF from a rate control or rhythm control perspective has been studied via a meta-analysis of 5 randomized trials. 7 Rate control in combination with anticoagulation as front-line ...

The temporary pause follows reports of four cases of neurovascular events in the US external evaluation study.

Atrial fibrillation, or A-fib, is an irregular heart rhythm that increases a person's risk of stroke, heart failure and even ...

It beats around 60-100 times per minute when you're resting. If you have atrial fibrillation, though, your heart can beat out of rhythm, too fast, or too slow. Untreated AFib might also make you ...